The murine PKR tumor suppressor gene is rearranged in a lymphocytic leukemia

Experimental Cell Research

Volumn 244, Issue 2, 1998, Pages 394-404

  Abraham, Ninan ^a,b   Jaramillo, Maria L ^a   Duncan, Peter I ^d   Méthot, Nathalie ^a   Icely, Pamela L ^a   Stojdl, David F ^a,b   Barber, Glen N ^c   Bell, John C ^a,b  

^a OTTAWA REGIONAL CANCER CENTRE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; INTERFERON; MUTANT PROTEIN; PHOSPHOTRANSFERASE;

ANIMAL CELL; ARTICLE; CELL GROWTH; ENZYME ACTIVITY; GENE REARRANGEMENT; LYMPHATIC LEUKEMIA; MUTATION; NONHUMAN; PRIORITY JOURNAL; RNA BINDING; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE;

EID: 0032212772     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4201     Document Type: Article

References (57)

1. Pestka S., Langer J. A., Zoon K. C., Samuel C. E. Interferons and their actions. Annu. Rev. Biochem. 56:1987;727-777.
2. Meurs E., Chong K., Galabru J., Thomas N. S. B., Kerr I. M., Williams B. R. G., Hovanessian A. G., Thomas N. S., Williams B. R. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell. 62:1990;379-390.
3. Krust B. G. J. Further Characterisation of the Protein Kinase Activity Mediated by Interferon in Mouse and Human Cells. J. Biol. Chem. 259:1984;8494-8498.
4. Roy S., Katze M. G., Parkin N. T., Edery I., Hovanessian A. G., Sonenberg N. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science. 247:1990;1216-1219.
5. Black T. L., Safer B., Hovanessian A., Katze M. G. The cellular 68000-Mr protein kinase is highly autophosphorylated and activated yet significantly degraded during poliovirus infection: implications for translational regulation. J. Virol. 63:1989;2244-2251.
6. Lee S. B., Esteban M. The interferon-induced double-stranded RNA-activated human p68 protein kinase inhibits the replication of Vaccinia virus. Virology. 193:1993;1037-1041.
7. Gupta S. L., Holmes S. L., Mehra L. L. Interferon action against reovirus: activation of interferon-induced protein kinase in mouse L-292 cells upon reovirus infection. Virology. 120:1982;495-499.
8. Nilsen T. W., Maroney P. A., Baglioni C. Inhibition of protein synthesis in reovirus-infected HeLa cells with elevated levels of interferon-induced protein kinase activity. J. Biol. Chem. 257:1982;14593-14596.
9. Rice A. P., Duncan R., Hershey J. W. B., Kerr I. M. Double-stranded RNA-dependent protein kinase and 2-5A system are both activated in interferon-treated, encephalomyocarditis virus-infected HeLa cells. J. Virol. 54:1985;894-898.
10. Lengyel P. Biochemistry of interferons and their actions. Annu. Rev. Biochem. 51:1982;251-282.
11. Kostura M., Mathews M. B. Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol. Cell. Biol. 9:1989;1576-1586.
12. Farrell P. J., Balkow K., Hunt T., Jackson R. J., Trachsel H. Phosphorylation of initiation factor eIF2 and the control of reticulocyte protein synthesis. Cell. 11:1977;187-200.
13. Galabru J., Hovanessian A. G., Hovanessian A. Autophosphorylation of the protein kinase dependent on double stranded RNA. J. Biol. Chem. 262:1987;15538-15544.
14. Samuel C. E. The eIF-2X protein kinases, regulators of translation in eukaryotes from yeasts to humans. J. Biol. Chem. 268:1993;7603-7606.
15. Safer B. 2B or not 2B: Regulation of the Catalytic utilization of elF-2. Cell. 33:1983;7-8.
16. Proud C. G. Guanine nucleotides, protein phosphorylation and the control of translation. Trends Biochem. Sci. 11:1986;73-77.
17. Svensson C., Akusjarvi G. Adenovirus VA RNA I mediates a translational stimulation which is not restricted to the viral mRNAs. EMBO J. 4:1985;957-964.
18. O'Malley R. P., Duncan R. F., Hershey J. W. B., Mathews M. B. Modification of protein synthesis initiation factors and shut-off of host protein synthesis in adenovirus-infected cells. Virology. 168:1989;112-118.
19. de Benedetti A., Baglioni C. Inhibition of mRNA binding to ribosomes by localized activation of dsRNA-dependent protein kinase. Nature. 311:1984;79-81.
20. Kaufman R. J. Translational control mediated by eukaryotic initiation factor-2 is restricted to specific mRNAs in transfected cells. Mol. Cell. Biol. 7:1987;1568-1571.
21. Katze M. G., Detjen B. M., Safer B., Krug R. M. Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral messenger RNAs. Mol. Cell. Biol. 6:1986;1741-1750.
22. Samuel C. E. Role of the RNA-dependent protein kinase in the regulated expression of genes in transfected cells. Pharmacol. Ther. 54:1992;307-317.
23. Clemens M. Suppression with a difference. Nature. 360:1992;210-211.
24. Lengyel P. Tumor-suppressor genes:News about the interferon connection. Proc. Natl. Acad. Sci. USA. 90:1993;5893-5895.
25. Chong K. L., Feng L., Schappert K., Meurs E., Donahue T. F., Friesen J. D., Hovanessian A. G., Williams B. R. G., Williams B. R. Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J. 11:1992;1553-1562.
26. Koromilas A. E., Roy S., Barber G. N., Katze M. G., Sonenberg N. Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science. 257:1992;1685-1689.
27. Meurs E. F., Galabru J., Barber G. N., Katze M. G., Hovanessian A. G. Tumour suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA. 90:1993;232-236.
28. Barber G. N., Edelhoff S., Katze M. G., Disteche C. M. Chromosomal assignment of the interferon-inducible double-stranded RNA-dependent protein kinase (PKR) to human chromosome 2p21-p22 and mouse chromosome 17 E2. Genomics. 16:1993;765-767.
29. Mitelman F., Kaneko Y., Trent J. M. Report of the committee on chromosome changes in neoplasia. Cytogenet. Cell Genet. 55:1990;358-386.
30. Icely P. L., Gros P., Bergeron J. J. M., Devault A., Afar D. E. H., Bell J. C. TIK, a novel serine/threonine kinase, is recognized by antibodies directed against phosphotyrosine. J. Biol. Chem. 266:1991;16073-16077.
31. Barber G. N., Tomita J., Hovanessian A. G., Meurs E., Katze M. G. Functional expression and characterization of the interferon-induced double-stranded RNA activated p68 kinase from Escherichia coli. Biochemistry. 30:1991;10356-10361.
32. Katze M. G., Wambach M., Wong M.-L., Garfinkel M., Meurs E., Chong K., Williams B. R. G., Hovanessian A. G., Barber G. N. Functional expression and RNA binding analysis of the interferon-induced double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system. Mol. Cell. Biol. 11:1991;5497-5505.
33. Roth M. B., Zahler A. M., Stolk J. A. A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription. J. Cell Biol. 115:1991;587-596.
34. Ellis L., Clauser E., Morgan D. O., Edery M., Roth R. A., Rutter W. J. Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell. 45:1986;721-732.
35. Tam J. P. Synthetic peptide vaccine design:Synthesis and properties of a high-density multiple antigenic peptide system. Proc. Natl. Acad. Sci. USA. 85:1988;5409-5413.
36. Barber G. N., Tomita J., Garfinkel M. S., Meurs E., Hovanessian A., Katze M. G. Detection of protein kinase homologues and viral RNA-binding domains utilizing polyclonal antiserum prepared against a baculovirus-expressed dsRNA-activated 68,000-Da protein kinase. Virology. 191:1992;670-679.
37. Barber G. N., Wambach M., Wong M. L., Dever T. E., Hinnebusch A. G., Katze M. G. Translational regulation by the interferon-induced double-stranded-RNA-activated 68-kDa protein kinase. Proc. Natl. Acad. Sci. USA. 90:1993;4621-4625.
38. Thomis D. C., Doohan J. P., Samuel C. E. Mechanism of interferon action: cDNA structure, expression and regulation of the interferon-induced, RNA-dependent P1/eIF2alpha protein kinase from human cells. Virology. 188:1992;33-46.
39. Feng G., Chong K., Kumar A., Williams B. R. G. Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase. Proc. Natl. Acad. Sci. USA. 89:1992;5447-5451.
40. Kuhen K. L., Shen X., Carlisle E. R., Richardson A. L., Weier H. U., Tanaka H., Samuel C. E. Structural organization of the human gene (PKR) encoding an interferon-inducible RNA-dependent protein kinase (PKR) and differences from its mouse homolog. Genomics. 36:1996;197-201.
41. Krust B., Riviere Y., Hovanessian A. G. p68K kinase in different tissues and plasma of control and interferon-treated mice. Virology. 120:1982;240-246.
42. Tang Z., Coleman T. R., Dunphy W. G. Two distinct mechanisms for negative regulation of the Wee 1 protein kinase. EMBO J. 12:1993;3427-3436.
43. Lasky S. R., Jacobs B. L., Samuel C. E. Characterization of sites of phosphorylation in the interferon-induced phosphoprotein P1 from mouse fibroblasts: Evidence for two forms of P1. J. Biol. Chem. 257:1982;11087-11093.
44. Lindberg R. A., Quinn A. M., Hunter T. Dual-specificity protein kinases: Will any hydroxyl do. Trends Biochem. Sci. 17:1992;114-119.
45. Baier L. J., Shors T., Shors S. T., Jacobs B. L. The mouse antiphosphotyrosine immunoreactive kinase, TIK, is indistinguishable from the double-stranded RNA-dependent, interferon-induced protein kinase, PKR. Nucleic Acids Res. 21:1993;4830-4835.
46. Hanks S. K., Quinn A. M., Hunter T. The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science. 241:1988;42-52.
47. Green S. R., Mathews M. B. Two RNA-binding motifs in the double-stranded RNA-activated protein kinase, DAI. Genes Dev. 6:1992;2478-2490.
48. St. Johnston D., Brown N. H., Gall J. G., Jantsch M. A conserved double-stranded RNA-binding domain. Proc. Natl. Acad. Sci. USA. 89:1992;10979-10983.
49. Songyang Z., Shoelson S. E., Chaudhuri M., Gish G., Pawson T., Haser W. G., King F., Roberts T., Ratnofsky S., Lechleider R. J., Neel B. G., Birge R. B., Fajardo J. E., Chou M. M., Hanafusa H., Schaffhausen B., Cantley L. C. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
50. Songyang Z., Shoelson S. E., McGlade J., Olivier P., Pawson T., Bustelo X. R., Barbacid M., Sabe H., Hanafusa H., Yi T., Ren R., Baltimore D., Ratnofsky S., Feldman R. A., Cantley L. C. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk and VAV. Mol. Cell. Biol. 14:1994;2777-2785.
51. Lee S. B., Rodriguez D., Rodriguez J. R., Esteban M. The apoptosis pathway triggered by the interferon-induced protein kinase PKR requires the third basic domain, initiates upstream of Bcl-2, and involves ICE-like proteases. Virology. 231:1997;81-88.
52. Wong A. H., Tam N. W., Yang Y. L., Cuddihy A. R., Li S., Kirchhoff S., Hauser H., Decker T., Koromilas A. E. Physical association between STAT1 and the interferon-inducible protein kinase PKR and implications for interferon and double-stranded RNA signaling pathways. EMBO J. 16:1997;1291-1304.
53. Polyak S. J., Tang N., Wambach M., Barber G. N., Katze M. G. The P58 cellular inhibitor complexes with the interferon-induced, double-stranded RNA-dependent protein kinase, PKR, to regulate its autophosphorylation and activity. J. Biol. Chem. 271:1996;1702-1707.
54. Basu S., Panayiotidis P., Hart S. M., He L. Z., Man A., Hoffbrand A. V., Ganeshaguru K. Role of double-stranded RNA-activated protein kinase in human hematological malignancies. Cancer Res. 57:1997;943-947.
55. Langland J. O., Jacobs B. L. Cytosolic double-stranded RNA-dependent protein kinase is likely a dimer of partially phosphorylated Mr = 66,000 subunits. J. Biol. Chem. 267:1992;10729-10736.
56. Cosentino G. P., Venkatesan S., Serluca F. C., Green S. R., Mathews M. B., Sonenberg N. Double-stranded-RNA-dependent protein kinase and TAR RNA-binding protein form homo- and heterodimers in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;9445-9449.
57. Thomis D. C., Samuel C. E. Mechanism of interferon action: evidence for intermolecular autophosphorylation and autoactivation of the interferon-induced, RNA-dependent protein kinase PKR. J. Virol. 67:1993;7695-7700.